Company News-Beijing Jinhao Pharmaceutical Co., Ltd.

News Center

Focus · Conveyance

Professional knowledge

Company News

2026.02.06

EU CE Compliance | Jinhao Pharmaceutical’s Nipah Virus Nucleic Acid Detection Kit Supports Research and Disease Prevention

2026.01.26

An outbreak of Nipah virus has occurred in India, and Jinhao Pharmaceutical’s all‑premixed nucleic acid assay combined with colloidal gold antigen tests is supporting epidemic monitoring and control.

2025.12.01

World AIDS Day | Social Co-Governance, Upholding Core Principles While Innovating, Ending AIDS

2025.07.25

With the current chikungunya outbreak, Jinhao Pharmaceutical’s precise testing is supporting scientific prevention and control.

2022.12.15

Good News │ Beijing Jinhao Pharmaceutical Has Been Awarded the 2021 Beijing Science and Technology Progress Award!

2022.10.25

Beijing Jinhao Pharmaceutical’s real-time fluorescent quantitative PCR analyzer has obtained a Class III medical device registration certificate.

2022.10.24

Good news! Beijing Jinhao Pharmaceutical has been included in the first batch of Beijing municipal-level enterprise technology center establishment list for 2022.

2022.09.26

Long time no see—finally reunited! Kexin Bio and Jinhao Pharmaceutical made their debut at the 85th National Pharmaceutical Fair.

2022.09.18

A decisive move! Beijing Jinhao Pharmaceutical has supported the rapid testing of the mainland’s first confirmed case of monkeypox.

< 1 >

Jinhao Pharmaceutical

Follow us

Phone: 400-650-6787 | 010-67878866 | Address: Building 1, No. 7 Yuncheng Street, Beijing Economic-Technological Development Area, Beijing |

© 2026 Beijing Jinhao Pharmaceutical Co., Ltd. All rights reserved | Beijing ICP Filing No. 17020135-2